[1] Ferlay J, Soerjomataram I, Dikshit R, et al. (2015).Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, E3,59-86.
[2] Breast Cancer Facts & Figures 2017-2018. American Cancer Society, Inc. Williams Street, NW, Atlanta, GA 30303-1002 404-320-3333.2019.
[3] Mbeunkui F, Johann DJ Jr. (2009). Cancer and the tumor microenvironment: A review of an essential relationship. Cancer Chemother Pharmacol,63: 571-82.
[4] Whiteside TL. (2008). The tumor microenvironment and its role in promoting tumor growth. Oncogene,27: 5904-12.
[5] Deborah L H, Valerie S. (2011).Choosing the right cell line for breast cancer research. Breast Cancer Research, 13( 215):7 pages.
[6] Mc Menamin ÚC, Murray LJ, Hughes CM, et al. (2016). Statin use and breast cancer survival: a nationwide cohort study in Scotland. BMC Cancer, doi:10.1186/s12885 -016-2651-0.
[7] Rezano A, Ridhayanti F, Rangkuti AR, et al. (2020). Cytotoxicity of Simvastatin in Human Breast Cancer MCF-7 and MDA-MB-231 Cell Lines. Asian Pacific Journal of Cancer Prevention, doi:10.22034/APJCP.
[8] Hu MB, Zhang JW, Gao JB, et al. (2018). Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells. Ultrastructural Pathology, doi:10.1080/01913123.2018. 15224 06.
[9] Subramanian A, Shu-Uin G, Kae-Siang N, et al. (2012). Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells Do Not Transform to Tumor-Associated Fibroblasts in the Presence of Breast and Ovarian Cancer Cells, Unlike Bone Marrow Mesenchymal Stem Cells. Journal of Cellular Biochemistry, 113:1886–95.
[10] Wang HS, Hung SC, Peng ST, et al. (2004). Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells, 22:1330-37.
[11] Sarugaser R, Lickorish D, Baksh D, et al. (2004). Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells, 23:220–29.
[12] Gauthaman K, Yee FC, Cheyyatraivendran S, et al. (2012). Human Umbilical Cord Wharton’s Jelly Stem Cell (hWJSC) Extracts Inhibit Cancer Cell Growth in Vitro. Journal of Cellular Biochemistry, 113:2027-39.
[13] Ma Y, Hao X, Zhang S, et al. (2012). The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Res Treat, doi: 10.1007/s10549-011-1774-x.
[14] Li T, Zhang C, DingY, et al. (2015). Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA‑MB-231breast cancer cells through activation of the ERK pathway. ONCOLOGY REPORTS, doi: 10.3892/or.2015.4109.
[15] Qu Z, Xu H, Tian Y, et al. (2013). Atorvastatin Improves Microenvironment to Enhance the Beneficial Effects of BMSCs Therapy in a Rabbit Model of Acute Myocardial Infarction. Cell Physiol Biochem, doi: 10.1159/000354445.
[16] Oktaviono YH, Hutomo SA, Al-Farabi MJ, et al. (2020). Human umbilical cord blood-mesenchymal stem cell-derived secretome in combination with atorvastatin enhances endothelial progenitor cells proliferation and migration. F1000 Research, doi:org/ 10.12688/f1000research.23547.1.
[17] ATCC Credible leads to Incredible,(2019). [online] Available at: https://www.atcc.org/products/all/HTB-22. Aspx #culture method. [Accessed 26 October 2019].
[18] DSMZ collection. Safety Information, (2021). [online] Available at: Https://www.dsmz.de/collection/catalogue/human-and-animal-cell-lines/safety-information. [Accessed 26 February 2021].
[19]Mcf-7, ACC 115. data sheet,(2021). [online] Available at:https://www.dsmz.de/collection/catalogue/details/culture/acc-115. [Accessed 26 February 2021].
[20] Section 4. Cell line problems: identification and elimination,(2021). [online] Available at:Https://cellbank.nibiohn.go. jp/legacy/information/guidelines/ukcccr/cell_linessec4.html. [Accessed 26 February 2021].
[21] Langan TJ, Chou RC. (2011).Synchronization of mammalian cell cultures by serum deprivation. Methods Mol Biol,761:75-83.
[22] Ranjbaran H, Abediankenari S, Mohammadi M, et al. (2018).Wharton’s Jelly Derived-Mesenchymal Stem Cells:Isolation and Characterization. Acta Medica Iranica,56(1): 6 pages.
[23] Claire Mennan, Karina Wright, Atanu Bhattacharjee, et al. (2013). Isolation and Characterisation of Mesenchymal Stem Cells from Different Regions of the Human Umbilical Cord. BioMed Research International, doi:10.1155/2013/916136.
[24] Trilineage Differentiation of Multipotent Human Mesenchymal Stem Cells (MSCs) into Osteocytes, Adipocytes and Chondrocytes. (2021). [online] Available at:https://www.sigmaaldrich.com/technical-documents/protocols/biology/cell-culture/mesenchymal-stem-cell-differentiation.html. [Accessed 20 April 2021].
[25] Mirabdollahi M, HaghjooyJavanmard SH, Sadeghi-aliabadi H. (2019). An anticancer effect of umbilical cord-derived mesenchymal stem cell secretome on the breast cancer cell line. Cell Tissue Bank, doi:10.1007/s10561-019-09781-8.
[26] Dzobo K, Vogelsang M, Thomford NE, et al. (2016). Wharton’s Jelly-Derived Mesenchymal Stromal Cells and Fibroblast-Derived Extracellular Matrix Synergistically Activate Apoptosis in a p21-Dependent Mechanism in WHCO1 and MDA MB 231 Cancer Cells in Vitro. Hindawi Publishing Corporation Stem Cells International, doi:org/10.1155/2016/4842134.
[27] Sigma-Aldrich. Product Information. Dulbecco’s Modified Eagle’s Medium-low glucose. (2021). [online] Available at:https://www.sigmaaldrich.com/catalog/search? term=dmem&interface=All&N=0+4294407710&mode=match%20partialmax&lang=en®ion=IR&focus=product. [Accessed 26 February 2021].
[28] U.S. National Library of Medicine. Atorvastatin calcium.(2019). [online] Available at:https://pubchem.ncbi.nlm.nih. gov/compound/atorvastatin_calcium. [Accessed 26 October 2019].
[29] Product information. Atorvastatin(calcium salt).item number10493.cayman chemical company. August5,2018.
[30] Leila Jamalzadeh, Hosein Ghafoori, Reyhaneh Sariri, et al (2016). Cytotoxic Effects of Some Common Organic Solvents on MCF-7, RAW-264.7 and Human Umbilical Vein Endothelial Cells. Avicenna J Med Biochem, doi: 10.17795/ajmb-33453.
[31] Riss T L, Moravec R A, Niles A L, et al. Cell Viability Assays. Assay Guidance Manual. (2020) [online] Available at: https://www.ncbi.nlm.nih.gov/books/ NBK144065/?report=reader. [Accessed 3 September 2020].
[32] MTT Cell Proliferation Assay Instruction Guide. American Type Culture Collection. ATCC® 30-1010K. 2011.
[33] Sigma Aldrich. DAPI.(2021). [online] Available at:https://www.sigmaaldrich.com/catalog/product/sigma. [Accessed 20 April 2021].
[34] Justus C R, Leffler N, Echevarria M R, et al. (2014). In vitro Cell Migration and Invasion Assays. Journal of Visualized Experiments, doi:10.3791/51046.
[35] Calvin R. Justus,Nancy Leffler,Maria Ruiz-Echevarria,et al. (2014). In vitro Cell Migration and Invasion Assays. J Vis Exp, doi: 10.3791/51046.
[36] scientific reports.(2021) [online] Available at: https://www.nature.com/articles/srep14272/figures/3. [Accessed 20 April 2021].
[37] Lv FJ, Tuan RS, Cheung KMC, et al. (2014). Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells. Stem Cells,32:1408-1419.
[38] Phan BAP, Toth PP. (2014). Dyslipidemia in women: etiology and management. Int J Womens Health, doi: 10.2147/IJWH.S38133.
[39] Laverias G, Danilo C, Mercier I, et al. (2011). Role of Cholesterol in the Development and Progression of Breast Cancer. The American Journal of Pathology, doi: 10.1016/j.ajpath.2010.11.005.
[40] Pandyra AA, Mullen PJ, Goard CA, et al. (2015). Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death. Oncotarget, 6: 26909–21.
[41] Mullen PJ, Yu R, Longo J, et al. (2016) The interplay between cell signaling and the mevalonate pathway in cancer. Nat Rev Cancer, 16: 718–31.
[42] El-Sohemy A, Archer MC. (2000). Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations. Carcinogenesis, 21: 827–31.
[43] Steven G. (2004). Reducing cholesterol and overcoming drug resistance. Blood,104(6):1598-99.
[44] Campbell MJ, Esserman LJ, Zhou Y, et al. (2006). Breast cancer growth prevention by statins. Cancer Res, 66: 8707- 14.
[45] abcam. Nuclear condensation, DNA fragmentation and membrane disruption during apoptosis. (2021) [online] Available at:https://www.abcam.com/kits/nuclear-condensation-dna-fragmentation-and-membrane-disruption-during-apoptosis. [Accessed 20 April 2021].
[46] Mueck AO, Seeger H, Wallwiener D. (2003). Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells. Menopause: The Journal of the North American Menopause Society, doi: 10.1097/01. GME.0000055485.06076.00.
[47] Al-khafaji AHY, Arif IS. (2018). Evaluation of anti-proliferative activity of simvastatin and atorvastatin on MCF7 cell line compared with doxorubicin using MTT test. AJPS, doi: org/10.32947/ajps.18.02.0386.
[48] Martinez TA, Zeybek ND, Müftüoğlu S. (2018). Evaluation of the Cytotoxic and Autophagic Effects of Atorvastatin on MCF-7 Breast Cancer Cells. Balkan Med J, doi: 10.4274/balkanmedj.2017.0604.
[49] Kimbung S, Lettiero B, Feldt M, et al. (2016). High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer. Oncotarget,7(37): 59640-51.
[50] Shahrokhabadi KH, Baharara J, Zafar balanejad S, et al. (2014).The effect of atorvastatin on progress and proliferation of mcf7 breast cancer cell line. Journal of advances in medical and biomedical research, 21(88):11pages.
[51] Beckwitt CH. (2018). Breast cancer metastatic dormancy and emergence, a role for adjuvant statin therapy. Dissertation. University of Pittsburgh.
[52] Beckwitt C H, Shiraha K, Wells A. (2018). Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling. PLOS ONE, 15:22pages.
[53] H. Seeger, D. Wallwiener, A. O. Mueck. (2003). Statins Can Inhibit Proliferation of Human Breast Cancer Cells in Vitro. Exp Clin Endocrinol Diabetes, doi: 10.1055/s-2003-37501.
[54] S´anchez CA, Rodr´ıguez E, Varela E, et al. (2008). Statin-Induced Inhibition of MCF-7 Breast Cancer Cell Proliferation is Related to Cell Cycle Arrest and Apoptotic and Necrotic Cell Death Mediated by an Enhanced Oxidative Stress. Cancer Investigation, doi: 10.1080/07357900701874658.
[55] George M. Mekhail, Amany O. Kamel, Gehanne A.S. et al. (2012). Anticancer effect of atorvastatin nanostructured polymeric micelles based on stearyl-grafted chitosan. International Journal of Biological Macromolecules, 51:351-63.
[56] Chao KC, Yang HT, Chen MW. (2012). Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell–cell contact and internalization. J. Cell. Mol. Med, doi:10.1111/j.1582-4934.2011.01459. x.
[57] Alkhaitb M H, Al-Saedi DA. (2017). Cytotoxic Effect of the Combination of Gemcitabine and Atorvastatin Loaded in Nanoparticle on the MCF-7 Breast Cancer Cells and HFS
Human Foreskin Cells. Current Nanoscience, 13: 625-33.
[58] Ma Q, Gao Y, Xu P, et al. (2019). Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB). Bio Med Research International, doi: 10.1155/2019/3235021.
[59] Zalatnai, A. (2005). Potential Role of Cell Cycle Synchronizing Agents in Combination Treatment Modalities of Malignant Tumors. In Vivo, 19: 85–91.
[60] Ayuzawa R, Doi C, Rachakatla RS, et al. (2009). Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Letters, doi: 10.1016/j.canlet.02.011.
[61] Mück A.O, Seeger H, Wall wiener D. (2004). Inhibitory effect of statins on the proliferation of human breast cancer cells. Int Journal of Clinical Pharmacology and Therapeutics,42(12):695-700.
[62] Mi W, Lin Q, Childress C, et al. (2015). Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration. Oncogene, 34: 3095-3106.